In this interview, Prasad Raje, CEO of LGM Pharma, explains how LGM’s API sourcing, CDMO and analytical services work together to take products from development to commercial launch, and how recent shocks have reshaped supply‑chain strategy, from onshoring and diversification to investments in patient‑proximate manufacturing and women’s‑health dosage forms.
TWENTYFOURSEVENBIOPHARMA